Re: The Diversity of Providers on the Family Medicine Team

References

1. 1.↵
   1. Bazemore A,
   2. Wingrove P,
   3. Peterson L,
   4. Petterson S

   . The diversity of providers on the family medicine team. J Am Board Fam Med 2016;29:8–9.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Carter BL,
   2. Coffey CS,
   3. Ardery G,
   4. et al

   . Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes 2015;8:235–43.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Cranor CW,
   2. Bunting BA,
   3. Christensen DB

   . The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (2003) 2003;43:173–84.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Gnjidic D,
   2. Le Couteur DG,
   3. Kouladjian L,
   4. Hilmer SN

   . Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012;28:237–53.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Murray MD,
   2. Ritchey ME,
   3. Wu J,
   4. Tu W

   . Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease. Arch Intern Med 2009;169:757–63. Erratum in: Arch Intern Med 2009;169:1184.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Vinks TH,
   2. Egberts TC,
   3. de Lange TM,
   4. de Koning FH

   . Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging 2009;26:123–33.

   OpenUrlCrossRefPubMedWeb of Science